Target intelligence / Profile preview

Novel transcript, sense intronic to MSANTD2 (ENSG00000279342)

Target: ENSG00000279342
Molecular classification: Other (lncRNA)

Overview

This entity is an annotated long non-coding RNA, not a known receptor, enzyme, or protein target. It has no established functional or disease association, drug interactions, or known mechanism of action. It is positioned within an intron of the MSANTD2 gene, but unlike MSANTD2, it does not encode a known protein. There is no current evidence supporting its use as a therapeutic target[2].

Other names: GC11M124790GC11M124858GC11M126688GC11M130347GC11M134199GC11M137558

Beyond the preview

Go deeper on Novel transcript, sense intronic to MSANTD2 (ENSG00000279342).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, sense intronic to MSANTD2 (ENSG00000279342).

Explore the full profile